You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0463 Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through 3 years: long-term data from the future 1 and future 2 studies

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Psoriatic arthritis
SAT0463 Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through 3 years: long-term data from the future 1 and future 2 studies
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017201
Jul 20171805
Aug 20175405
Sep 20172001
Oct 201730013
Nov 20172804
Dec 20173001
Jan 20182004
Feb 20182203
Mar 20182603
Apr 20181602
May 20183004
Jun 20184600
Jul 20181802
Aug 20181400
Sep 20182808
Oct 20182201
Nov 20182405
Dec 2018601
Jan 2019602
Feb 20191001
Mar 2019604
Apr 2019202
May 20191808
Jun 2019602
Jul 2019602
Aug 2019402
Sep 2019402
Oct 2019403
Dec 2019001
Jan 2020600
Feb 2020607
Mar 2020202
Apr 2020203
May 2020803
Jun 2020602
Jul 20201404
Aug 2020401
Sep 20202201
Oct 2020803
Nov 2020800
Dec 2020803
Feb 2021802
Mar 20211002
Apr 20211005
May 2021303
Jun 2021002
Jul 2021008
Aug 2021005
Sep 2021007
Oct 20212013
Nov 202110015
Dec 20212407
Jan 202228014
Feb 2022401
Mar 20221001
Apr 2022401
May 20221206
Jun 20221603
Jul 20221001
Aug 20221707
Sep 20221105
Oct 2022805
Nov 20221009
Dec 2022501
Jan 2023406
Feb 2023400
Mar 2023600
Apr 2023201
May 2023003
Jun 20232201
Jul 2023804
Aug 2023202
Sep 2023400
Oct 2023202
Nov 2023201
Dec 2023800
Jan 2024701
Feb 2024203
Mar 2024408
Total8930276